Allergen-specific Immunotherapy
Authors:
- Anthony J. FrewAFAnthony J. Frew
- Helen E. SmithHSHelen E. Smith
- 5 February 2016
- book chapter
- Published by Elsevier
- p. 133-150
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trialJournal of Allergy and Clinical Immunology, 2012
- Hundred years of allergen immunotherapyClinical & Experimental Allergy, 2011
- Immunological mechanisms of sublingual allergen-specific immunotherapyAllergy, 2011
- Allergen immunotherapy: A practice parameter third updateJournal of Allergy and Clinical Immunology, 2011
- Injection allergen immunotherapy for asthmaCochrane Database of Systematic Reviews, 2010
- Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort studyAnnals of Allergy, Asthma & Immunology, 2010
- Sublingual immunotherapy induces IL-10–producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviationJournal of Allergy and Clinical Immunology, 2007
- Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT studyAllergy, 2007
- Cost‐effectiveness of grass allergen tablet (GRAZAX®) for the prevention of seasonal grass pollen induced rhinoconjunctivitis – a Northern European perspectiveClinical & Experimental Allergy, 2007
- Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 2006